Predictors of treatment response and survival outcomes in patients with advanced cardiac AL amyloidosis
Joshua Gustine(Boston University), Vaishali Sanchorawala(Boston Medical Center), Deepa M. Gopal(Boston University), Tracy Joshi(Boston University), Andrew Staron(Boston University), Frederick L. Ruberg(Boston University), Omar K. Siddiqi(Boston University), Lisa Mendelson(Boston University)
Cited by 29
Related Papers
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
|American Journal of Hematology|2005|1.4k
High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study
|Annals of Internal Medicine|2004|615
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis
|Circulation Heart Failure|2019|560
Systemic immunoglobulin light chain amyloidosis
|Nature Reviews Disease Primers|2018|550